Shanghai Jiao Tong University School of Medicine: Carcinoma, Squamous Cell trials

The registry lists 10 Carcinoma, Squamous Cell studies with Shanghai Jiao Tong University School of Medicine as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 6Phase 3 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCCRecruitingNCT05125055Phase 2/3
• Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC PatientsRecruitingNCT05069857Phase 2
• Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 StageRecruitingNCT02290145Phase 2
• GDF15 Based TPF Induction Chemotherapy for OSCC PatientsRecruitingNCT02285530Phase 2
• Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and SurgeryCompletedNCT05455632
• Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma PatientsCompletedNCT04473716Phase 1
• Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I TrialCompletedNCT04413214Phase 1
• Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell CarcinomaCompletedNCT04393506Phase 1
• A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC PatientsTerminatedNCT02285543Phase 2
• TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell CarcinomaCompletedNCT01542931Phase 2/3